Repository corticotropin injection in patients with advanced symptomatic sarcoidosis: retrospective analysis of medical records
Background: Repository corticotropin injection (RCI) has regulatory approval for many indications, including symptomatic sarcoidosis. This large case series of patients with advanced symptomatic sarcoidosis treated with RCI describes patient characteristics, RCI utilization patterns, concomitant the...
Main Authors: | Ishveen Chopra, Yimin Qin, John Kranyak, Jack R. Gallagher, Kylee Heap, Susan Carroll, George J. Wan |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-11-01
|
Series: | Therapeutic Advances in Respiratory Disease |
Online Access: | https://doi.org/10.1177/1753466619888127 |
Similar Items
-
Cost per response analysis of repository corticotropin injection versus other alternative treatments for acute exacerbations of multiple sclerosis
by: George J Wan, et al.
Published: (2020-12-01) -
Corrigendum: Cost per response analysis of repository corticotropin injection versus other alternative treatments for acute exacerbations of multiple sclerosis
by: George J Wan, et al.
Published: (2021-01-01) -
Repository Corticotropin Injection for Treatment of Idiopathic Inflammatory Myopathies
by: Aarat Patel, et al.
Published: (2016-01-01) -
Cost-Effectiveness of Repository Corticotropin Injection versus Standard of Care for the Treatment of Active Rheumatoid Arthritis
by: Bindra J, et al.
Published: (2021-05-01) -
Repository corticotropin injection in patients with rheumatoid arthritis resistant to biologic therapies
by: Fischer PA, et al.
Published: (2018-02-01)